Key facts
- Notable investors include Chengdu Bio-Town Investment, Shanghai Healthcare Capital, Ennovation Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Nano Ribo
- ·The full record, as it builds
Funding rounds
No funding rounds for Nano Ribo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nano Ribo
Operator and developer of a biotechnology intended to serve the vaccine and drug industry. The company focuses on the research and development of biological medicines and vaccines and aims to build a profound scientific-driven R&D process, from target validation to drug discovery, pre-clinical evaluation and clinical trial designs.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- nanoribo.com/
- Ownership
- Privately Held (backing)
Nano Ribo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nano Ribo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nano Ribo in its N-PORT filings yet. We sweep new filings monthly.